Zymeworks (ZYME) Short-term Investments (2021 - 2026)

Zymeworks (ZYME) has 6 years of Short-term Investments data on file, last reported at $120.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 36.3% year-over-year to $120.4 million; the trailing twelve-month figure through Mar 2026 stood at $120.4 million (down 36.3% YoY), and the FY2025 full-year result was $187.6 million, up 17.52% from the prior year.
• Short-term Investments eased to $120.4 million in Q1 2026, from $187.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $259.2 million in Q2 2024 to a low of $70.2 million in Q3 2022.
• A 5-year average of $175.2 million and a median of $187.1 million in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 186.59% in 2023 and plunged 36.3% in 2026, its largest moves.
• Tracing ZYME's Short-term Investments over 5 years: stood at $91.3 million in 2022, then surged by 137.37% to $216.8 million in 2023, then retreated by 26.34% to $159.7 million in 2024, then advanced by 17.52% to $187.6 million in 2025, then sank by 35.81% to $120.4 million in 2026.
• Business Quant data shows ZYME's Short-term Investments at $120.4 million in Q1 2026, $187.6 million in Q4 2025, and $187.1 million in Q3 2025.